查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046569

心理健康與治療聊天機器人市場－全球產業規模、佔有率、趨勢、機會、預測：按技術、組件、應用、地區和競爭格局分類，2021-2031年

Chatbots for Mental Health and Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Component, By Application By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球心理健康和治療聊天機器人市場預計將從 2025 年的 2.3383 億美元大幅成長到 2031 年的 4.0573 億美元，複合年成長率為 9.62%。

這些人工智慧驅動的數位應用利用自然語言處理技術模擬治療性對話，並提供情緒追蹤、認知行為療法和情感支持等服務。推動這一市場發展的主要動力是全球對便利心理健康服務日益成長的需求。這些自動化系統提供即時、匿名且經濟高效的援助，填補了醫療專業人員嚴重短缺造成的空白。此外，由於這些平台全天候運作，處於危機中的人們能夠及時獲得干涉，成為更廣泛的醫療保健系統中至關重要的第一道防線。

市場概覽
預測期 2027-2031
市場規模：2025年 2.3383億美元
市場規模：2031年 4.0573億美元
複合年成長率：2026-2031年 9.62%
成長最快的細分市場 自然語言處理
最大的市場 北美洲

儘管人工智慧技術發展勢頭強勁，但該領域仍面臨許多挑戰，包括如何將這些工具整合到標準臨床工作流程中，以及合格的專業人士對其倫理影響和有效性的質疑。確保演算法回應的安全性和臨床有效性仍然是一項重大挑戰，這延緩了醫療系統對這些技術的正式核准。專業人士的這種猶豫態度在近期的行業數據中也得到了印證。根據美國心理學會統計，到2024年，只有11%的心理學家表示每月至少使用一次人工智慧工具，凸顯了技術能力與實際臨床應用之間的巨大差距。

市場促進因素

全球精神健康障礙盛行率的不斷上升是推動自動化治療解決方案普及的主要動力。隨著世界各地的醫療保健系統努力應對患者需求與醫護人員供給之間日益擴大的差距，使用數位工具作為一種擴充性且即時的干涉手段正變得越來越普遍。各種心理壓力源的激增凸顯了對便利醫療服務的迫切需求。根據 Headspace 於 2024 年 3 月發布的《2024 年員工心理健康狀況報告》，77% 的員工表示工作壓力對他們的身體健康產生了負面影響，這表明有大量人口需要持續的支持。因此，聊天機器人正成為心理健康醫療基礎設施的重要組成部分，透過提供全天候分診和認知行為療法支持，幫助使用者應對可能面臨的長時間等待。

隨著需求的成長，對數位心理療法的資金和投資也激增，加速了這些平台的技術成熟度和商業化部署。創業投資公司正大力投資人工智慧新創公司，以增強自然語言處理能力，並提高演算法療法的安全性和臨床效用。例如，MobiHealthNews在2024年3月報道稱，臨床人工智慧公司Limbic籌集了1,400萬美元，用於將其聊天機器人服務拓展到新市場。越來越多的證據顯示這些技術具有顯著的有效性，也為資金的湧入提供了支持。發表在《自然醫學》雜誌上並被《行為健康商業》雜誌在2024年4月引用的一項研究表明，使用Limbic Access人工智慧聊天機器人使非二元性別者使用心理健康服務的積極性提高了179%。這表明，這些獲得資助的技術可以有效地填補醫療服務中的一個重要缺口。

市場挑戰

全球心理健康和治療聊天機器人市場面臨的主要障礙之一是，合格的專業人士對這些工具的安全性和臨床有效性始終持懷疑態度，這嚴重阻礙了它們融入現有工作流程。專業人士的這種猶豫不決阻止了市場全面擴展到正規醫療領域，導致這些應用僅限於面向消費者（D2C）的領域，而無法成為醫保覆蓋和醫生推薦的干涉措施。如果無法獲得醫療界的積極信任，這些平台就無法從單純的健康輔助工具轉變為治療護理的核心要素，這限制了它們在醫院系統和保險公司中的應用。

近期的數據凸顯了醫療保健領域信任度嚴重不足的問題，也印證了這種抵觸情緒。根據美國醫學會 (AMA) 預測，到 2025 年，47% 的醫生會認為「加強監管」是建立人們對人工智慧工具應用信心的關鍵監管措施。這項數據表明，相當一部分醫療專業人員仍然對現有的安全規程持懷疑態度。因此，市場面臨合法性障礙，而缺乏專家支持對於機構的廣泛應用也阻礙了其發展。

市場趨勢

隨著企業加速採用人工智慧驅動的工具來擴展心理健康支援並應對員工倦怠，企業健康和員工協助計畫 (EAP) 正在重塑市場格局。在應對不斷飆升的醫療保健成本和提高生產力的驅動下，雇主正從傳統的被動式 EAP 模式轉向主動式、數位化優先的解決方案，以提供即時支援。這項轉變源自於企業領導者的強烈需求。根據 Headspace 於 2025 年 3 月發布的《2025 年員工心理健康狀況報告》，94% 的人力資源負責人對提供人工智慧驅動的心理健康福利感興趣，89% 的員工表示願意使用此類人工智慧工具。

同時，隨著開發者努力區分醫療級干預措施與未經監管的健康應用程式，數位治療方法的臨床療效檢驗和認證已成為重中之重。隨著資料安全和演算法有效性受到日益嚴格的審查，市場相關人員正積極尋求嚴格的監管流程，以獲得保險資格並融入正規醫療保健系統。這些檢驗的解決方案面臨著顯而易見的進入門檻。根據醫療保健記者協會2025年11月發布的報告，迄今為止，美國食品藥物管理局（FDA）核准的數位心理健康設備不足20種，凸顯了這個新興治療方法領域所需的獨特性和嚴格標準。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球心理健康與治療聊天機器人市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 透過科技（機器學習與深度學習、自然語言處理等）
    • 按組件（SaaS、其他）
    • 按應用方式（互動式介面、行為模式辨識等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美心理健康與治療聊天機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲心理健康與治療聊天機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區心理健康與治療聊天機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲心理健康與治療聊天機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲心理健康與治療聊天機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球心理健康與治療聊天機器人市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Wysa Ltd
  • Ginger
  • Woebot Health
  • Marigold Health
  • Bark Technologies
  • Mindstrong Health
  • BioBeats
  • Lyra Health
  • Cognoa
  • X2AI

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20227

The Global Chatbots for Mental Health and Therapy Market is projected to expand significantly, growing from USD 233.83 Million in 2025 to USD 405.73 Million by 2031, registering a CAGR of 9.62%. These AI-driven digital applications utilize natural language processing to simulate therapeutic interactions, delivering services such as mood tracking, cognitive behavioral techniques, and emotional support. The market is primarily driven by the escalating global need for accessible psychological care, as these automated systems provide immediate, anonymous, and cost-effective assistance that bridges the gap caused by a severe shortage of human practitioners. Additionally, the ability of these platforms to operate twenty-four hours a day ensures that individuals in crisis receive timely intervention, acting as a crucial first line of defense within the broader healthcare ecosystem.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 233.83 Million
Market Size 2031USD 405.73 Million
CAGR 2026-20319.62%
Fastest Growing SegmentNatural Language Processing
Largest MarketNorth America

Despite this positive growth trajectory, the sector encounters significant obstacles regarding the integration of these tools into standard clinical workflows and the skepticism of licensed professionals regarding their ethical implications and efficacy. Ensuring that algorithmic responses are secure and clinically valid remains a major challenge, often delaying the formal endorsement of these technologies by healthcare systems. This professional hesitation is evident in recent industry data; according to the American Psychological Association, only 11% of psychologists reported using artificial intelligence tools in their practice at least monthly in 2024, highlighting the substantial divide between technological capability and actual clinical adoption.

Market Driver

The escalating global prevalence of mental health disorders acts as the primary catalyst driving the adoption of automated therapeutic solutions. As healthcare systems around the world struggle with a widening gap between patient demand and the available workforce of human practitioners, digital tools are increasingly being used to provide scalable, immediate intervention. This surge in diverse psychological stressors underscores the urgent need for accessible care; according to the '2024 Workforce State of Mind' report by Headspace in March 2024, 77% of employees reported that work stress had negatively impacted their physical health, indicating a massive population requiring consistent support. Consequently, chatbots are becoming an essential part of the mental healthcare infrastructure, offering 24/7 triage and cognitive behavioral assistance to manage the rising volume of users who might otherwise face prolonged wait times.

Concurrent with this demand, a surge in funding and investment for digital mental therapeutics is accelerating the technical refinement and commercial deployment of these platforms. Venture capital firms are heavily financing AI-driven startups to enhance natural language processing capabilities, thereby increasing the safety and clinical utility of algorithmic therapy. For instance, MobiHealthNews reported in March 2024 that the clinical AI firm Limbic raised $14 million to expand its chatbot services into new markets. This financial influx is supported by growing evidence of efficacy; according to a study published in Nature Medicine and cited by Behavioral Health Business in April 2024, the use of the Limbic Access AI chatbot resulted in a 179% increase in engagement with mental health services among non-binary individuals, proving that these funded technologies can successfully bridge critical gaps in care delivery.

Market Challenge

The primary impediment hindering the Global Chatbots for Mental Health and Therapy Market is the persistent skepticism among licensed professionals regarding the safety and clinical efficacy of these tools, which severely complicates their integration into established workflows. This professional hesitation restricts the market from fully expanding into the formal healthcare sector, effectively confining these applications to the direct-to-consumer space rather than allowing them to become reimbursed, prescriber-endorsed interventions. Without the active trust of the medical community, these platforms cannot transition from supplemental wellness aids to core components of therapeutic care, thereby limiting their adoption by hospital systems and insurance providers.

This resistance is substantiated by recent data highlighting the magnitude of the trust deficit within the medical field. According to the American Medical Association, in 2025, 47% of physicians ranked increased oversight as the primary regulatory action required to build their trust in adopting artificial intelligence tools. This statistic indicates that a significant portion of the workforce remains unconvinced by current safety protocols. Consequently, the market faces a validity barrier, where growth is capped by the inability to secure the professional endorsements necessary for widespread institutional deployment.

Market Trends

The expansion into Corporate Wellness and Employee Assistance Programs (EAPs) is reshaping the market as organizations increasingly deploy AI-driven tools to scale mental health benefits and address workforce burnout. Employers are transitioning from traditional, reactive EAP models to proactive, digital-first solutions that offer immediate support, driven by the need to manage rising healthcare costs and improve productivity. This shift is substantiated by strong demand from organizational leadership; according to the '2025 Workforce State of Mind' report by Headspace in March 2025, 94% of HR leaders expressed interest in offering mental health benefits that utilize artificial intelligence, with 89% of employees indicating comfort in using these AI-leveraged tools.

Simultaneously, the pursuit of clinical validation and digital therapeutic certifications has become a critical priority as developers seek to differentiate medical-grade interventions from unregulated wellness applications. Amidst growing scrutiny over data safety and algorithmic efficacy, market players are actively navigating rigorous regulatory pathways to secure reimbursable status and integration into formal healthcare systems. The high barrier to entry for these validated solutions is evident; according to the Association of Health Care Journalists in November 2025, the FDA has cleared fewer than 20 digital mental health devices to date, highlighting the exclusivity and stringent standards required for this emerging class of therapeutics.

Key Market Players

  • Wysa Ltd
  • Ginger
  • Woebot Health
  • Marigold Health
  • Bark Technologies
  • Mindstrong Health
  • BioBeats
  • Lyra Health
  • Cognoa
  • X2AI

Report Scope

In this report, the Global Chatbots for Mental Health and Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chatbots for Mental Health and Therapy Market, By Technology

  • Machine learning and Deep learning
  • Natural Language Processing
  • Others

Chatbots for Mental Health and Therapy Market, By Component

  • Saas
  • Others

Chatbots for Mental Health and Therapy Market, By Application

  • Conversational Interfaces
  • Behavioral Pattern Recognition
  • Others

Chatbots for Mental Health and Therapy Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chatbots for Mental Health and Therapy Market.

Available Customizations:

Global Chatbots for Mental Health and Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chatbots for Mental Health and Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Machine learning and Deep learning, Natural Language Processing, Others)
    • 5.2.2. By Component (Saas, Others)
    • 5.2.3. By Application (Conversational Interfaces, Behavioral Pattern Recognition, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Chatbots for Mental Health and Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Component
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Chatbots for Mental Health and Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Chatbots for Mental Health and Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Chatbots for Mental Health and Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By Application

7. Europe Chatbots for Mental Health and Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Component
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Chatbots for Mental Health and Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By Application
    • 7.3.2. France Chatbots for Mental Health and Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Chatbots for Mental Health and Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Chatbots for Mental Health and Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Chatbots for Mental Health and Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By Application

8. Asia Pacific Chatbots for Mental Health and Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Component
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Chatbots for Mental Health and Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By Application
    • 8.3.2. India Chatbots for Mental Health and Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Chatbots for Mental Health and Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Chatbots for Mental Health and Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Chatbots for Mental Health and Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By Application

9. Middle East & Africa Chatbots for Mental Health and Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Component
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Chatbots for Mental Health and Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Chatbots for Mental Health and Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Chatbots for Mental Health and Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By Application

10. South America Chatbots for Mental Health and Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Component
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Chatbots for Mental Health and Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Chatbots for Mental Health and Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Chatbots for Mental Health and Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Chatbots for Mental Health and Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Wysa Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Ginger
  • 15.3. Woebot Health
  • 15.4. Marigold Health
  • 15.5. Bark Technologies
  • 15.6. Mindstrong Health
  • 15.7. BioBeats
  • 15.8. Lyra Health
  • 15.9. Cognoa
  • 15.10. X2AI

16. Strategic Recommendations

17. About Us & Disclaimer